Werewolf Therapeutics (HOWL) announced the appointment of Steven Bloom as Chief Business Officer. Bloom brings more than 35 years of experience in the life sciences industry leading teams in corporate development, commercial planning, corporate affairs, and strategic consulting.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOWL:
- Promising Investment in Werewolf Therapeutics: Strong Financials and Strategic Partnerships Drive Growth Prospects
- Unlocking Broader Therapeutic Potential: Andrew Fein’s Buy Rating on Werewolf Therapeutics
- Werewolf Therapeutics Faces Geopolitical Risks Amid Changing Trade Policies with China
- Werewolf Therapeutics Reports 2024 Financial Results and Progress
- Werewolf Therapeutics reports Q4 EPS (46c), consensus (31c)